Nexus Surgical re-appoints Ms. Neha Bhageria as independent director
- Re-appointment of Ms. Neha Kailash Bhageria as Independent Non-Executive Woman Director
- Second five-year term effective from September 30, 2026 to September 29, 2031
- Approval required from members at the 35th Annual General Meeting
- Director has background in corporate finance and governance for listed companies
*this image is generated using AI for illustrative purposes only.
Nexus Surgical and Medicare Limited re-appointed Ms. Neha Kailash Bhageria as an Independent Non-Executive Woman Director for a second five-year term. The appointment is effective from September 30, 2026, until September 29, 2031.
The Board of Directors approved the re-appointment on September 2, 2026, based on the recommendation of the Nomination and Remuneration Committee. The move requires shareholder approval at the company’s 35th Annual General Meeting.
Ms. Bhageria brings experience in corporate finance, legal functions, and governance for listed entities. She holds DIN 09217784 and is not related to any other director of the company.
Director Profile
| Detail | Information |
|---|---|
| Name | Ms. Neha Kailash Bhageria |
| DIN | 09217784 |
| Role | Independent Non-Executive Woman Director |
| Term Duration | 5 years |
| Effective Date | September 30, 2026 |
| Expiry Date | September 29, 2031 |
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ms. Bhageria affirmed she is not debarred by SEBI or any other authority and is not disqualified under Section 164 of the Companies Act, 2013.
Historical Stock Returns for Nexus Surgical & Medicare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.84% | +32.34% | +28.81% | +29.43% | +33.59% | 0.0% |
How might Ms. Bhageria's background in corporate finance and governance influence Nexus Surgical's strategic decisions over the next five years?
What specific initiatives or regulatory challenges is the Nomination and Remuneration Committee prioritizing that led to the recommendation for this re-appointment?
Could the re-appointment signal a shift in the company's approach to compliance and risk management in the healthcare sector?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
